Hsin-Yu Chen

5PUBLICATIONS
10CO-AUTHORS
Molecular targetsBiomechanicsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 26, 2026
Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study.

|Jul 11, 2026
Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes.

|Jun 26, 2026
Long-Term Cognitive Impairment After CAR-T Therapy Versus Autologous Stem Cell Transplantation: A Propensity Score-Matched Cohort Study.

|Jun 11, 2026
Target Trial Emulation of Second-Generation Versus First-Generation Tyrosine Kinase Inhibitors in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

|May 06, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

Pageof 1

Frequent Collaborators

4 joint publications

Po-Huang Chen

4 joint publications

Cho-Hao Lee

3 joint publications

Hong-Jie Jhou

3 joint publications

Wei-Cheng Chang